Arkolith/Insider Trading/CLVS/Form 4

Harding Thomas C.

See RemarksClovis Oncology, Inc. (CLVS) · full profile →Form 4 · filed Sep 6, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 2, 2022Sell(S)172$1.20$2064K
Sep 2, 2022Sell(S)1K$1.20$2K18K
Sep 1, 2022Option exercise(M)508——4K
Sep 1, 2022Option exercise(M)3K——19K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 1, 2022Option exercise(M)508—$03K
Sep 1, 2022Option exercise(M)3K—$029K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-030419) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML